Oral tacrolimus noninferior to intravenous cyclophosphamide for lupus nephritis
1. Oral tacrolimus was noninferior to intravenous cyclophosphamide for lupus nephritis disease...
Read MoreApr 27, 2022
1. Oral tacrolimus was noninferior to intravenous cyclophosphamide for lupus nephritis disease...
Read MoreApr 26, 2022
1. At 10-year follow-up, patients with early-stage breast cancer who underwent mastectomy with...
Read MoreApr 25, 2022
1. Amongst a cohort of adults in Japan, a comprehensive laughter-intervention program...
Read MoreApr 25, 2022
1. Initiating supplemental parenteral nutrition (PN) at 3 days after major abdominal surgery was...
Read MoreApr 25, 2022
1. In this study, telemedicine bridge clinics had high show rate and allowed patients to fill...
Read MoreApr 25, 2022
1. Objective response rate was 35%, with 1 patient showing a complete response and 7 showing a...
Read MoreApr 25, 2022
1. In this non-randomized controlled trial including 501 patients with COVID-19-associated...
Read MoreApr 25, 2022
1. Among a group of US medical students, those with multiple marginalized identities (based on...
Read MoreApr 24, 2022
1. Widespread underlying SARS-CoV-2 seropositivity was observed in Gauteng province, South Africa,...
Read MoreApr 23, 2022
1. In this study, medication prescribed for opioid use disorder amongst pregnant women often...
Read MoreApr 23, 2022
1. Based on the study, there was no evidence of increased risk for acute myocardial infarction...
Read MoreApr 23, 2022
1. Based on the study, there is a small absolute risk for shoulder conditions after vaccination....
Read MoreApr 23, 2022
1. Oral baricitinib is superior to placebo regarding hair regrowth at 36 weeks. 2. Oral...
Read MoreApr 23, 2022
1. Compared to lower dose primaquine, higher dose primaquine had higher efficacy in preventing...
Read MoreApr 23, 2022
1. Compared to intravenous ertapenem, oral tebipenem pivoxil hydrobromide was non-inferior in the...
Read MoreApr 23, 2022
1. Compared to medical care alone, treatment of large cerebral infarctions had better functional...
Read MoreApr 23, 2022
1. Rilzabrutinib was active and 400mg twice daily was identified as the dose for further testing...
Read MoreApr 23, 2022
1. Between 1998 to 2015, mortality rates for myocardial infarction, stroke, and pulmonary embolism...
Read MoreApr 22, 2022
1. This cohort study concluded that the concomitant use of antipsychotic and antidepressant...
Read More